Reestimation of Medicare Spending for Semaglutide After Most Favored Nation and Medicare Drug Price Negotiation Announcements

Value in Health 2026

View at publisher

Authors: Sean D. Sullivan, Victoria W. Dayer, Adam Kasle, Iman Nourhussein, Ryan N. Hansen

DOI: 10.1016/j.jval.2026.01.016

Cited by: 0

References: 1

Fields of Study & Subjects

Pharmaceutical Economics and Policy Healthcare Policy and Management Health Systems Economic Evaluations Quality of Life

References 1